[go: up one dir, main page]

DE602004011228D1 - Verfahren und zusammensetzungen zur bestimmung glycierter proteine - Google Patents

Verfahren und zusammensetzungen zur bestimmung glycierter proteine

Info

Publication number
DE602004011228D1
DE602004011228D1 DE602004011228T DE602004011228T DE602004011228D1 DE 602004011228 D1 DE602004011228 D1 DE 602004011228D1 DE 602004011228 T DE602004011228 T DE 602004011228T DE 602004011228 T DE602004011228 T DE 602004011228T DE 602004011228 D1 DE602004011228 D1 DE 602004011228D1
Authority
DE
Germany
Prior art keywords
compositions
glycated proteins
determining glycated
chimeric proteins
determining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004011228T
Other languages
English (en)
Other versions
DE602004011228T2 (de
Inventor
Chong-Sheng Yuan
Abhijit Datta
Yuping Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Atomics Corp
Original Assignee
General Atomics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Atomics Corp filed Critical General Atomics Corp
Publication of DE602004011228D1 publication Critical patent/DE602004011228D1/de
Application granted granted Critical
Publication of DE602004011228T2 publication Critical patent/DE602004011228T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
    • C12N9/0032—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with oxygen as acceptor (1.5.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE602004011228T 2003-07-17 2004-07-16 Verfahren und zusammensetzungen zur bestimmung glyzierter proteine Expired - Lifetime DE602004011228T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/622,893 US7153666B2 (en) 2003-07-17 2003-07-17 Methods and compositions for determination of glycated proteins
US622893 2003-07-17
PCT/US2004/022908 WO2005017136A1 (en) 2003-07-17 2004-07-16 Methods and compositions for determination of glycated proteins

Publications (2)

Publication Number Publication Date
DE602004011228D1 true DE602004011228D1 (de) 2008-02-21
DE602004011228T2 DE602004011228T2 (de) 2009-01-02

Family

ID=34063265

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004011228T Expired - Lifetime DE602004011228T2 (de) 2003-07-17 2004-07-16 Verfahren und zusammensetzungen zur bestimmung glyzierter proteine

Country Status (7)

Country Link
US (2) US7153666B2 (de)
EP (1) EP1651759B1 (de)
JP (2) JP4966009B2 (de)
AT (1) ATE383418T1 (de)
CA (1) CA2532557C (de)
DE (1) DE602004011228T2 (de)
WO (1) WO2005017136A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6951728B2 (en) * 2002-05-10 2005-10-04 Lifescan, Inc. Multilayer reagent test strips to quantify glycated protein in a physiological sample
US7153666B2 (en) * 2003-07-17 2006-12-26 General Atomics Methods and compositions for determination of glycated proteins
US8187831B2 (en) 2003-09-19 2012-05-29 General Atomics Determination of ions using ion-sensitive enzymes
EP1693461B1 (de) * 2003-11-19 2011-05-11 Sekisui Medical Co., Ltd. Verfahren zum testen von glykosyliertem protein
GB0418651D0 (en) * 2004-08-20 2004-09-22 Medical Res Council Method
EP2044444B1 (de) * 2006-07-25 2013-03-20 General Atomics Verfahren zur bestimmung des anteils an glykiertem hämoglobin
US7943385B2 (en) 2006-07-25 2011-05-17 General Atomics Methods for assaying percentage of glycated hemoglobin
ES2541114T3 (es) * 2007-11-20 2015-07-16 Siemens Healthcare Diagnostics Inc. Métodos para la detección de hemoglobina glicosilada
US8673646B2 (en) * 2008-05-13 2014-03-18 General Atomics Electrochemical biosensor for direct determination of percentage of glycated hemoglobin
WO2022189357A1 (en) 2021-03-08 2022-09-15 Universiteit Gent Treatment of skin diseases with fructosyl-amino acid oxidase

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2713581A (en) 1949-02-23 1955-07-19 Montclair Res Corp Certain tetrazolium salts and process for preparing them
GB738585A (en) 1952-07-17 1955-10-19 May & Baker Ltd Improvements in or relating to tetrazolium compounds
GB1513488A (en) 1976-11-11 1978-06-07 Lushina O Method of preparing 2h-tetrazolium chlorides and 2h-tetrazolium chlorides hydrochlorides
GB8308483D0 (en) 1983-03-28 1983-05-05 Health Lab Service Board Secretion of gene products
US4588684A (en) 1983-04-26 1986-05-13 Chiron Corporation a-Factor and its processing signals
JPS59219270A (ja) 1983-05-30 1984-12-10 Wako Pure Chem Ind Ltd テトラゾリウム塩を含有する溶液の安定化方法
BE901119A (fr) 1984-11-23 1985-03-15 Wallone Region Procede de preparation de plasmides vecteurs capables de transformer un hote bacterien escherichia coli et d'y promouvoir et controler l'expression d'un adn heterologue.
EP0196864A3 (de) 1985-03-25 1988-03-23 Cetus Corporation Behandlung und Sekretion von rekombinanten Proteinen mittels alkalischer Phosphatase, dazu verwendbare DNA-Sequenzen und mittels dieser Sequenzen transformierte Zellen
US4948729A (en) 1985-03-25 1990-08-14 Cetus Corporation Production of soluble recombinant proteins
CA1282024C (en) 1985-05-31 1991-03-26 Pyare Khanna Glucose-6-phosphate dehydrogenase conjugates useful in polyiodothyronine assays
DE3611227A1 (de) 1986-04-04 1987-10-08 Boehringer Mannheim Gmbh Verfahren und reagenz zur bestimmung von substraten oder enzymaktivitaeten
US5196314A (en) 1986-04-04 1993-03-23 Boehringer Mannheim Gmbh Process and reagent for the determination of substrates or enzyme activities
US5008006A (en) * 1987-06-05 1991-04-16 Miller Jan D Chemical conditioning of fine coal for improved flotation and pyrite rejection
US5030563A (en) 1987-07-07 1991-07-09 Genetics Institute, Inc. Bacterial hypersecretion using mutant repressor sequence
CA1335357C (en) 1987-10-30 1995-04-25 Timothy M. Rose Expression systems for preparation of polypeptides in prokaryotic cells
EP0372005A4 (de) 1987-10-30 1990-06-26 Oncogen Expressionssysteme zur erzeugung von polypeptiden in prokaryotischen zellen.
US5516682A (en) 1988-07-05 1996-05-14 University Of Maryland Subtilin variant of enhanced stability and activity
JP2742281B2 (ja) 1988-12-29 1998-04-22 旭化成工業株式会社 グルコース―６―リン酸デヒドロゲナーゼ遺伝子
JPH04504504A (ja) 1989-04-13 1992-08-13 エンジィマティクス　インコーポレイテッド 酸化還元測定システムにて妨害物質を除去するための流体不溶性酸化剤の使用
US5171670A (en) 1989-05-12 1992-12-15 The General Hospital Corporation Recombinant dna method for production of parathyroid hormone
US5312759A (en) 1989-12-20 1994-05-17 Iatron Laboratories, Inc. Method for measurement of fructosamines using 1,2-quinones
DE4024158A1 (de) 1990-07-30 1992-02-06 Boehringer Mannheim Gmbh Klonierung und ueberexpression von glucose-6-phosphat-dehydrogenase aus leuconostoc dextranicus
US5244796A (en) 1990-10-12 1993-09-14 Syracuse University Cloned leuconostoc mesenteroides glucose-6-phosphate dehydrogenase genes and method of making glucose-6-phospate dehydrogenase
MY107664A (en) 1991-01-17 1996-05-30 Kao Corp Novel alkaline proteinase and process for producing the same
AU2592692A (en) 1991-09-20 1993-04-27 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Isolation and characterization of cdna of plasmodium falciparum glucose-6-phosphate dehydrogenase
US5789221A (en) 1994-03-03 1998-08-04 Kyogo Daiichi Kagaku Co., Ltd. Fructosyl amino acid oxidase and process for producing the same
CA2156226C (en) 1994-08-25 1999-02-23 Takayuki Taguchi Biological fluid analyzing device and method
US5712138A (en) 1994-10-05 1998-01-27 Kyoto Daiichi Kagaku Co., Ltd. Fructosyl amino acid oxidase
IL117350A0 (en) * 1995-03-09 1996-07-23 Procter & Gamble Proteinase k variants having decreased adsorption and increased hydrolysis
EP0737744B1 (de) 1995-04-11 2005-11-30 ARKRAY, Inc Fructosyl-Aminosäureoxidase und Verfahren zu deren Herstellung
WO1996034977A1 (en) 1995-05-05 1996-11-07 Genzyme Limited Determination of glycated proteins
JP3217687B2 (ja) 1996-02-16 2001-10-09 オリエンタル酵母工業株式会社 新規ヘキソキナーゼ
IL120587A (en) 1996-04-04 2000-10-31 Lifescan Inc Reagent test strip for determination of blood glucose
JPH1033177A (ja) 1996-07-23 1998-02-10 Kdk Corp フルクトシルアミノ酸オキシダーゼ
US5710248A (en) 1996-07-29 1998-01-20 University Of Iowa Research Foundation Peptide tag for immunodetection and immunopurification
US5856104A (en) 1996-10-28 1999-01-05 Affymetrix, Inc. Polymorphisms in the glucose-6 phosphate dehydrogenase locus
US5879921A (en) 1996-11-07 1999-03-09 Novo Nordisk A/S Recombinant expression of a glucose oxidase from a cladosporium strain
US6069297A (en) 1996-12-09 2000-05-30 Sloan-Kettering Institute For Cancer Research Glucose-6-phosphate dehydrogenase deficient mice and methods of using same
US6127345A (en) 1997-01-21 2000-10-03 Smithkline Beecham Corporation Polynucleotides encoding the glucose 6-phosphate dehydrogenase of Streptococcus pneumoniae
WO1998048043A1 (en) 1997-04-24 1998-10-29 Kyoto Daiichi Kagaku Co., Ltd. Method for enzymatically assaying saccharification protein
JP3987900B2 (ja) 1997-11-26 2007-10-10 アークレイ株式会社 糖化タンパク質の測定方法
GB9824282D0 (en) 1998-11-05 1998-12-30 Microbiological Research Agenc Delivery of superoxide dismutase to neuronal cells
US6352835B1 (en) 1998-11-17 2002-03-05 Kyoto Daiichi Kagaku Co. Ltd. Method of measuring substance in sample using a redox reaction
JP3949854B2 (ja) * 1999-10-01 2007-07-25 キッコーマン株式会社 糖化蛋白質の測定方法
CN1300763A (zh) 1999-12-23 2001-06-27 复旦大学 一种新的多肽－已糖激酶蛋白12和编码这种多肽的多核苷酸
CN1313391A (zh) 2000-03-15 2001-09-19 上海博德基因开发有限公司 一种新的多肽——人已糖激酶蛋白10和编码这种多肽的多核苷酸
CN1323837A (zh) 2000-05-16 2001-11-28 上海博德基因开发有限公司 一种新的多肽——人已糖激酶蛋白11和编码这种多肽的多核苷酸
EP1404820A2 (de) 2000-05-19 2004-04-07 Millennium Pharmaceuticals, Inc. 50365, ein mitglied der menschlichen hexokinase-familie und dessen verwendung
JP4931320B2 (ja) 2000-06-21 2012-05-16 協和発酵バイオ株式会社 新規なグルコース−６−リン酸デヒドロゲナーゼ
CN1333350A (zh) 2000-07-07 2002-01-30 上海博德基因开发有限公司 一种新的多肽——已糖激酶蛋白9.68和编码这种多肽的多核苷酸
DE10105911A1 (de) 2001-02-09 2002-08-14 Roche Diagnostics Gmbh Expression der rekombinanten Proteinase K aus Tritirachium album in Hefe
DE10105912A1 (de) 2001-02-09 2002-08-14 Roche Diagnostics Gmbh Rekombinante Proteinase K
DE10155505A1 (de) 2001-11-13 2003-05-22 Basf Ag Gene die für Glucose-6-Phosphat-Dehydrogenase Proteine codieren
US7153666B2 (en) * 2003-07-17 2006-12-26 General Atomics Methods and compositions for determination of glycated proteins

Also Published As

Publication number Publication date
EP1651759B1 (de) 2008-01-09
WO2005017136A1 (en) 2005-02-24
US7153666B2 (en) 2006-12-26
US20080241880A1 (en) 2008-10-02
CA2532557A1 (en) 2005-02-24
JP2007531499A (ja) 2007-11-08
JP4966009B2 (ja) 2012-07-04
US20050014935A1 (en) 2005-01-20
CA2532557C (en) 2014-04-15
EP1651759A1 (de) 2006-05-03
JP2011224025A (ja) 2011-11-10
DE602004011228T2 (de) 2009-01-02
ATE383418T1 (de) 2008-01-15

Similar Documents

Publication Publication Date Title
ATE540319T1 (de) Verfahren für die bestimmung von fk506
TW200745556A (en) Biomarkers for liver fibrotic injury
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
WO2002032925A3 (en) Protein scaffolds for antibody mimics and other binding proteins
DE602004026912D1 (de) Formulierungen und verfahren zum denaturieren von proteinen
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
DE602004021281D1 (de) Kolorimetrische substrate, kolorimetrische sensoren und verwendungsverfahren
DE602004011228D1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
ATE299589T1 (de) Verfahren zur bestimmung von substanzen mittels der evaneszenzfeldmethode
DE60333486D1 (de) Fluoreszenzproteine aus copepoda-spezies und verfahren zur verwendung davon
WO2005054516A3 (en) Peptide nucleic acid probes for analysis of certain staphylococcus species
DE602004030041D1 (de) Verfahren und zusammensetzungen zur identifikation von rna-bindenden proteinen
WO2005019831A3 (en) Methods for reducing complexity of a sample using small epitope antibodies
ATE414701T1 (de) Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren
ATE392621T1 (de) Verfahren zur quantifizierung von glykiertem protein
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
ATE462803T1 (de) Kit und verfahren zum nachweis von urothelkarzinom
ATE288589T1 (de) Verfahren zur analyse von proteinen
WO2005018552A3 (en) Heparin binding proteins: sensors for heparin detection
DE60138192D1 (de) Verfahren zur quantifizierung der akt-protein-expression
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
PL1977244T3 (pl) Rozróżnianie bakteryjnego i wirusowego zapalenia opon mózgowych

Legal Events

Date Code Title Description
8364 No opposition during term of opposition